| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8652840 | The Annals of Thoracic Surgery | 2018 | 7 Pages |
Abstract
Major morbidity and mortality rates SCA-TAVR are equivalent to TF-TAVR. The SCA should be the preferred secondary access site for TAVR because it offers procedural and clinical outcomes comparable to TF-TAVR and applies to most patients who are not TF candidates.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Thomas G. MD, John T. MD, Robert C. MD, G. Michael MD, David H. MD, John V. MD, George L. MD, G. Chad MD, Jia PhD, Jeffrey J. MD, Michael J. MD,